CellSeed Inc
TSE:7776

Watchlist Manager
CellSeed Inc Logo
CellSeed Inc
TSE:7776
Watchlist
Price: 471 JPY -4.85% Market Closed
Market Cap: 16.3B JPY
Have any thoughts about
CellSeed Inc?
Write Note

Relative Value

The Relative Value of one CellSeed Inc stock under the Base Case scenario is 84.84 JPY. Compared to the current market price of 471 JPY, CellSeed Inc is Overvalued by 82%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
84.84 JPY
Overvaluation 82%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
9
vs Industry
14
Median 3Y
40.9
Median 5Y
25.3
Industry
8.1
vs History
vs Industry
Median 3Y
-9.2
Median 5Y
-6
Industry
23
vs History
vs Industry
Median 3Y
-9.4
Median 5Y
-7.3
Industry
23.4
vs History
vs Industry
Median 3Y
-9.1
Median 5Y
-7.9
Industry
27.3
vs History
9
vs Industry
8
Median 3Y
3.6
Median 5Y
3.3
Industry
2.6
vs History
11
vs Industry
12
Median 3Y
30.3
Median 5Y
19.2
Industry
8.1
vs History
11
vs Industry
6
Median 3Y
53.7
Median 5Y
32.3
Industry
9.6
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-4.5
Industry
4.3
vs History
vs Industry
Median 3Y
-8
Median 5Y
-4.5
Industry
3.8
vs History
vs Industry
Median 3Y
-7.2
Median 5Y
-5.5
Industry
6
vs History
vs Industry
Median 3Y
-7.1
Median 5Y
-5.4
Industry
3.8
vs History
6
vs Industry
4
Median 3Y
15.9
Median 5Y
11.9
Industry
4.8

Multiples Across Competitors

Competitors Multiples
CellSeed Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
CellSeed Inc
TSE:7776
15.8B JPY 79 -16.5 -17.2 -17.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 015 917.2 -175 931.2 -213 636.5 -211 198.6
US
Abbvie Inc
NYSE:ABBV
352.5B USD 6.3 69.4 17 26.2
US
Amgen Inc
NASDAQ:AMGN
174.8B USD 5.4 41.3 18.9 35.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
133.2B USD 12.5 -277.5 28.2 29.6
US
Gilead Sciences Inc
NASDAQ:GILD
120.3B USD 4.3 955 10.6 10.6
US
Epizyme Inc
F:EPE
94.1B EUR 1 903.2 -485.6 -528.9 -514.8
AU
CSL Ltd
ASX:CSL
137.9B AUD 6.1 34.4 21.1 26.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
91.2B USD 6.6 19.6 18 20.1
US
Seagen Inc
F:SGT
39.3B EUR 18.3 -56.2 -60.4 -54.5
NL
argenx SE
XBRU:ARGX
33.2B EUR 18.3 -128.3 -103.1 -75.1
P/E Multiple
Earnings Growth
JP
CellSeed Inc
TSE:7776
Average P/E: 223.9
Negative Multiple: -16.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -175 931.2 N/A
US
Abbvie Inc
NYSE:ABBV
69.4
412%
US
Amgen Inc
NASDAQ:AMGN
41.3
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -277.5
42%
US
Gilead Sciences Inc
NASDAQ:GILD
955
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -485.6 N/A
AU
CSL Ltd
ASX:CSL
34.4
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.6
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -128.3 N/A
EV/EBITDA Multiple
EBITDA Growth
JP
CellSeed Inc
TSE:7776
Average EV/EBITDA: 19
Negative Multiple: -17.2
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -213 636.5 N/A
US
Abbvie Inc
NYSE:ABBV
17
28%
US
Amgen Inc
NASDAQ:AMGN
18.9
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.6
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -528.9 N/A
AU
CSL Ltd
ASX:CSL
21.1
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -103.1 N/A
EV/EBIT Multiple
EBIT Growth
JP
CellSeed Inc
TSE:7776
Average EV/EBIT: 24.7
Negative Multiple: -17.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -211 198.6 N/A
US
Abbvie Inc
NYSE:ABBV
26.2
88%
US
Amgen Inc
NASDAQ:AMGN
35.7
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
29.6
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.6
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A
AU
CSL Ltd
ASX:CSL
26.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
20.1
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -75.1 N/A

See Also

Discover More
Back to Top